XOMA Co. (NASDAQ:XOMAP – Get Free Report) announced a quarterly dividend on Wednesday, March 18th. Stockholders of record on Thursday, April 2nd will be given a dividend of 0.5391 per share on Wednesday, April 15th. This represents a c) annualized dividend and a dividend yield of 8.3%. The ex-dividend date of this dividend is Thursday, April 2nd.
XOMA Price Performance
Shares of XOMAP opened at $25.89 on Thursday. The company’s fifty day moving average price is $26.12 and its 200-day moving average price is $26.38. XOMA has a 1-year low of $24.96 and a 1-year high of $30.00.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
